United Kingdom· GB-APID-4107011000001100
Tilade 2mg/dose inhaler
A nedocromil product containing nedocromil, registered in United Kingdom by Sanofi. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Nedocromil is registered in 2 of 19 countries.
Countries holding a registration under ATC R03BC03 (nedocromil), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Nedocromil · ATC R03BC03
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Nedocromil
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- R03BC03
- ATC class
- Nedocromil
- Defined daily dose
- 8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for nedocromil.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nedocromil · interactions on record
5 records
- 5 moderate
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nedocromil in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Spain · Tilavist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2eae30e8-5826-433b-9ad3-57b6bd4ff804 GET /v1/drugs/2eae30e8-5826-433b-9ad3-57b6bd4ff804?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4107011000001100",
"desc": "Tilade 2mg/dose inhaler (Sanofi)",
"form": "Pressurised inhalation",
"vpid": "42296711000001109",
"source": "dmd",
"vtm_id": "776880008",
"strength": "2 mg",
"substance": "Nedocromil",
"ingredient": "Nedocromil sodium",
"supplier_code": "9190711000001101"
}See everything about nedocromil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.